JP2020500834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020500834A5 JP2020500834A5 JP2019511334A JP2019511334A JP2020500834A5 JP 2020500834 A5 JP2020500834 A5 JP 2020500834A5 JP 2019511334 A JP2019511334 A JP 2019511334A JP 2019511334 A JP2019511334 A JP 2019511334A JP 2020500834 A5 JP2020500834 A5 JP 2020500834A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- cdrh1
- cdrl1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201607147P | 2016-08-26 | ||
| SG10201607147P | 2016-08-26 | ||
| SG10201700393P | 2017-01-17 | ||
| SG10201700393P | 2017-01-17 | ||
| SG10201700521V | 2017-01-20 | ||
| SG10201700521V | 2017-01-20 | ||
| SG10201703234U | 2017-04-19 | ||
| SG10201703234U | 2017-04-19 | ||
| PCT/SG2017/050424 WO2018038684A1 (en) | 2016-08-26 | 2017-08-28 | Macrophage stimulating protein receptor (or ron - recepteur d' origine nantais) antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020500834A JP2020500834A (ja) | 2020-01-16 |
| JP2020500834A5 true JP2020500834A5 (https=) | 2020-10-08 |
Family
ID=61246095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019511334A Pending JP2020500834A (ja) | 2016-08-26 | 2017-08-28 | マクロファージ刺激タンパク質受容体（又はＲＯＮ（Ｒｅｃｅｐｔｅｕｒ ｄ′Ｏｒｉｇｉｎｅ Ｎａｎｔａｉｓ））抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11225515B2 (https=) |
| EP (1) | EP3504244A4 (https=) |
| JP (1) | JP2020500834A (https=) |
| CN (1) | CN109923129A (https=) |
| SG (2) | SG10201913858WA (https=) |
| WO (1) | WO2018038684A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170151281A1 (en) | 2015-02-19 | 2017-06-01 | Batu Biologics, Inc. | Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer |
| WO2020097193A1 (en) | 2018-11-06 | 2020-05-14 | The Regents Of The University Of California | Chimeric antigen receptors for phagocytosis |
| US11026973B2 (en) | 2019-04-30 | 2021-06-08 | Myeloid Therapeutics, Inc. | Engineered phagocytic receptor compositions and methods of use thereof |
| CN114981409A (zh) | 2019-09-03 | 2022-08-30 | 美洛德生物医药公司 | 用于基因组整合的方法和组合物 |
| WO2021066751A1 (en) * | 2019-10-02 | 2021-04-08 | Aslan Pharmaceuticals Pte. Ltd. | Antigen specific binding domains and antibody molecules |
| EP4041768A1 (en) * | 2019-10-09 | 2022-08-17 | StCube & Co. | Antibodies specific to glycosylated lag3 and methods of use thereof |
| US10980836B1 (en) | 2019-12-11 | 2021-04-20 | Myeloid Therapeutics, Inc. | Therapeutic cell compositions and methods of manufacturing and use thereof |
| WO2021202592A2 (en) * | 2020-03-30 | 2021-10-07 | Oregon Health & Science University | Monoclonal antibodies for intracellular delivery of payloads |
| EP4240367A4 (en) | 2020-11-04 | 2024-10-16 | Myeloid Therapeutics, Inc. | MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF |
| WO2022197949A2 (en) | 2021-03-17 | 2022-09-22 | Myeloid Therapeutics, Inc. | Engineered chimeric fusion protein compositions and methods of use thereof |
| BR112023023642A2 (pt) | 2021-05-11 | 2024-01-30 | Myeloid Therapeutics Inc | Métodos e composições para integração genômica |
| CN114317454B (zh) * | 2022-03-01 | 2023-10-03 | 天津一瑞生物科技股份有限公司 | 一种鼠抗oxa-48型碳青霉烯酶杂交瘤细胞株，单克隆抗体及应用 |
| CN117630376A (zh) * | 2022-08-26 | 2024-03-01 | 洛阳中科生物芯片技术有限公司 | 非洲猪瘟病毒p30蛋白阻断蛋白芯片抗体检测试剂盒及其制备方法 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| DK336987D0 (da) | 1987-07-01 | 1987-07-01 | Novo Industri As | Immobiliseringsmetode |
| GB8719042D0 (en) | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
| GB8720833D0 (en) | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8907617D0 (en) | 1989-04-05 | 1989-05-17 | Celltech Ltd | Drug delivery system |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| CA2090126C (en) | 1990-08-02 | 2002-10-22 | John W. Schrader | Methods for the production of proteins with a desired function |
| GB9112536D0 (en) | 1991-06-11 | 1991-07-31 | Celltech Ltd | Chemical compounds |
| GB9113120D0 (en) | 1991-06-18 | 1991-08-07 | Kodak Ltd | Photographic processing apparatus |
| GB9120467D0 (en) | 1991-09-26 | 1991-11-06 | Celltech Ltd | Anti-hmfg antibodies and process for their production |
| DE4137202A1 (de) | 1991-11-12 | 1993-05-13 | Industrieanlagen Betriebsges | Korrosionsgeschuetzte laengenverstellung |
| FR2716640B1 (fr) | 1994-02-28 | 1996-05-03 | Procedes Machines Speciales | Dispositif de centrage et de blocage d'une pièce en vue de son rodage à l'aide d'un rodoir à expansion. |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
| GB9812545D0 (en) | 1998-06-10 | 1998-08-05 | Celltech Therapeutics Ltd | Biological products |
| US6908963B2 (en) | 2001-10-09 | 2005-06-21 | Nektar Therapeutics Al, Corporation | Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
| ES2374068T3 (es) | 2002-12-03 | 2012-02-13 | Ucb Pharma, S.A. | Ensayo para identificar células productoras de anticuerpos. |
| CN100543135C (zh) * | 2003-02-28 | 2009-09-23 | 田边三菱制药株式会社 | 单克隆抗体及编码其的基因、药物组合物和诊断试剂 |
| GB0312481D0 (en) | 2003-05-30 | 2003-07-09 | Celltech R&D Ltd | Antibodies |
| ES2551439T5 (es) | 2003-07-01 | 2018-11-08 | Ucb Biopharma Sprl | Fragmentos Fab de anticuerpos modificados |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| DK1660090T3 (da) | 2003-08-14 | 2012-12-17 | Array Biopharma Inc | Quinazolin-analoger som receptor-tyrosinkinase-inhibitorer |
| GB0411186D0 (en) | 2004-05-19 | 2004-06-23 | Celltech R&D Ltd | Biological products |
| GB0412181D0 (en) | 2004-06-01 | 2004-06-30 | Celltech R&D Ltd | Biological products |
| GB0619291D0 (en) | 2006-09-29 | 2006-11-08 | Ucb Sa | Altered antibodies |
| CL2008003449A1 (es) * | 2007-11-21 | 2010-02-19 | Imclone Llc | Anticuerpo o fragmentos del mismo contra el receptor de proteína estimulante de macrófagos/ron; composición farmacéutica que lo comprende; uso para inhibir angiogénesis, crecimiento tumoral, proliferación, migración e invasión de células tumorales, activación de ron o fosforilación de mapk y/o akt; y uso para tratar cáncer. |
| JP2012504591A (ja) | 2008-10-02 | 2012-02-23 | レスピバート・リミテツド | ｐ３８ＭＡＰキナーゼ阻害剤 |
| TWI480050B (zh) * | 2009-02-10 | 2015-04-11 | Daiichi Sankyo Co Ltd | 抗－ｍｓｔ１ｒ抗體及其用途 |
| CA2785907A1 (en) * | 2009-12-29 | 2011-07-28 | Emergent Product Development Seattle, Llc | Ron binding constructs and methods of use thereof |
| AR082194A1 (es) * | 2010-07-06 | 2012-11-21 | Aveo Pharmaceuticals Inc | Anticuerpos anti-ron |
| UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| CN103946952A (zh) | 2011-09-16 | 2014-07-23 | 宾夕法尼亚大学董事会 | 用于治疗癌症的rna改造的t细胞 |
| EP3083695A4 (en) * | 2013-12-16 | 2017-11-15 | Texas Tech University System | Anti-ron monoclonal antibodies as a cytotoxic drug delivery system for targeted cancer therapy |
-
2017
- 2017-08-28 WO PCT/SG2017/050424 patent/WO2018038684A1/en not_active Ceased
- 2017-08-28 CN CN201780066397.6A patent/CN109923129A/zh active Pending
- 2017-08-28 JP JP2019511334A patent/JP2020500834A/ja active Pending
- 2017-08-28 SG SG10201913858WA patent/SG10201913858WA/en unknown
- 2017-08-28 EP EP17844047.5A patent/EP3504244A4/en not_active Withdrawn
- 2017-08-28 SG SG11201901597UA patent/SG11201901597UA/en unknown
- 2017-08-28 US US16/328,711 patent/US11225515B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020500834A5 (https=) | ||
| JP2019532056A5 (https=) | ||
| JP2022513420A5 (https=) | ||
| JP2022093564A5 (https=) | ||
| JP2022101693A5 (https=) | ||
| JP2024167313A5 (https=) | ||
| JP2023511774A5 (https=) | ||
| JP2018505177A5 (https=) | ||
| JP2020502271A5 (https=) | ||
| JP2020509027A5 (https=) | ||
| JP2021527640A5 (https=) | ||
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JP2010535713A5 (https=) | ||
| JP2023549537A5 (https=) | ||
| JP2017533694A5 (https=) | ||
| JP2016538318A5 (https=) | ||
| JP2015534579A5 (https=) | ||
| JP2015503909A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2010520290A5 (https=) | ||
| JP2023518153A5 (https=) | ||
| JP2024520666A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| JP2017521054A5 (https=) |